Indivior PLC (INDV) SEC Filings — 2025
41 SEC filings for Indivior PLC (INDV) in 2025.
Filings
- Indivior PLC 8-K Filing — 8-K · Dec 22, 2025
- Indivior PLC Reports Executive and Director Changes — 8-K · Dec 18, 2025
- Indivior PLC 8-K Filing — 8-K · Dec 15, 2025
- Indivior PLC Terminates Material Definitive Agreement — 8-K · Nov 20, 2025
- Indivior PLC 8-K Filing — 8-K · Nov 14, 2025
- Indivior PLC Files 8-K on Financials and Operations — 8-K · Oct 30, 2025
- Indivior's Q3 Net Income Surges 91% on Strong SUBLOCADE Sales — 10-Q · Oct 30, 2025
- Indivior PLC Files Amendment on Exit Costs — 8-K/A · Oct 30, 2025
- Indivior PLC Files 8-K Current Report — 8-K · Oct 1, 2025
- Indivior PLC Reports Exit/Disposal Costs — 8-K · Aug 26, 2025
- Indivior Appoints New Chief Medical Officer — 8-K · Aug 22, 2025
- Indivior PLC Files 8-K/A Amendment on Officer/Director Changes — 8-K/A · Aug 4, 2025
- Indivior PLC Files 8-K on Financials — 8-K · Jul 31, 2025
- Indivior's Net Income Holds Steady at $278M in H1 2025 — 10-Q · Jul 31, 2025
- Indivior PLC Files 8-K for June 30, 2025 — 8-K · Jun 30, 2025
- Indivior PLC Appoints New Chief Medical Officer — 8-K · Jun 24, 2025
- Indivior PLC Files 8-K Report — 8-K · Jun 2, 2025
- Indivior PLC Files 8-K: Other Events & Exhibits — 8-K · Jun 2, 2025
- Indivior PLC Files 8-K/A Amendment — 8-K/A · May 12, 2025
- Indivior PLC Files 8-K: Director Changes, Officer Appointments, Bylaw Amendments — 8-K · May 8, 2025
- Indivior PLC Files Q1 2025 10-Q — 10-Q · May 1, 2025
- Indivior Acquires Opiant Pharmaceuticals for $145M — 8-K · Apr 24, 2025
- Indivior PLC Files 8-K Report — 8-K · Mar 27, 2025
- Indivior PLC CFO Departs, Interim Appointed — 8-K · Mar 4, 2025
- Indivior PLC Reports Total Voting Rights Update — 6-K · Mar 3, 2025
- Indivior PLC 10-K Filing — 10-K · Mar 3, 2025
- Indivior PLC Files 6-K: Holdings Update — 6-K · Feb 28, 2025
- Indivior PLC Appoints Joseph Ciaffoni as CEO — 6-K · Feb 27, 2025
- Indivior PLC Files 6-K on Company Holdings — 6-K · Feb 25, 2025
- Indivior PLC: FDA Approves Sublocade Label Changes — 6-K · Feb 24, 2025
- Indivior PLC Files 6-K for FY 2024 Results — 6-K · Feb 20, 2025
- Indivior PLC: FDA Approval Delay for SUBLOCADE Label Changes — 6-K · Feb 12, 2025
- Indivior PLC Announces Share Transaction — 6-K · Feb 4, 2025
- Indivior PLC Appoints New Independent Non-Executive Director — 6-K · Feb 3, 2025
- Indivior Buys Back $10M in Shares — 6-K · Jan 28, 2025
- Indivior PLC Files 6-K on Company Holdings — 6-K · Jan 27, 2025
- Indivior Buys Back Shares — 6-K · Jan 21, 2025
- Indivior Buys Back 1M Shares for $10M — 6-K · Jan 14, 2025
- Indivior PLC Files 6-K with Historical US GAAP Financials — 6-K · Jan 10, 2025
- Indivior PLC Announces Share Transaction — 6-K · Jan 7, 2025
- Indivior PLC Reports Total Voting Rights Update — 6-K · Jan 2, 2025